Steven Stoner, PharmD, advises managed care teams to use rigorous diagnostic assessments, monitor adherence, and invest ...

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant ...

Early Intervention: Flagging non-adherence allows for earlier intervention, such as a phone call. This compassionate, ...

About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...

A new study has found that antidepressant resistance is more common than was thought: 48% of people with depression have tried at least two medications without effect, while 37% have tried four or ...

Cyclerion Therapeutics entered an agreement to integrate Medsteer's technology into CYC-126, its lead program in development for treatment-resistant depression.

Please provide your email address to receive an email when new articles are posted on . Overall, 11 polygenic scores were associated with treatment-resistant depression. Genetic predisposition for ...

Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...

Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer –– Comprehensive ...

Co-authored by Eugene Rubin, M.D., Ph.D., and Charles Zorumski, M.D. About one-third of patients with major depressive disorder do not respond adequately to medications and/or psychotherapy. If an ...

A study shows that a small, implanted device may provide substantial, long-lasting relief to people with the most severe treatment-resistant depression.